Mutations in the human CPA6 gene that reduce enzymatic activity in the extracellular matrix are associated with febrile seizures, temporal lobe epilepsy, and juvenile myoclonic epilepsy. This evidence concerns the gene CPA6 and juvenile myoclonic epilepsy.